(Q28196731)

1

0 references

R Lassila

2

0 references

J Westerbacka

3

0 references

S Vehkavaara

International Journal of Obesity

4

0 references

language of work or name

English

0 references

publication date

August 2003

0 references

published in

1 reference

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

volume

27

0 references

issue

8

0 references

page(s)

907-11

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Correlation of platelet aggregation, plasma factor activity, and megathrombocytes in diabetic subjects with and without vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Thromboxane biosynthesis and platelet function in type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Increase in the cytosolic concentration of calcium in platelets of diabetics type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Impaired Insulin-Induced Platelet Antiaggregating Effect in Obesity and In obese NIDDM Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Development of aspirin resistance in persons with previous ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of eryt

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Use of Polyethylene Glycol to Separate Free and Antibody-Bound Peptide Hormones in Radioimmunoassays†

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Platelet dysfunction in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Oxidative stress-induced isoprostane formation may contribute to aspirin resistance in platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

The platelet insulin receptor: Detection, partial characterization, and search for a function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

Platelet abnormalities in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

7 January 2021

Near-normal glycaemic control does not correct abnormal platelet reactivity in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

7 January 2021

Increased Platelet Aggregation in Early Diabetus Mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

7 January 2021

Evidence for abnormal platelet glycoprotein expression in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

7 January 2021

Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

7 January 2021

Decreased nitric oxide synthase activity in platelets from IDDM and NIDDM patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

7 January 2021

Reduction of platelet aggregation induced by euglycaemic insulin clamp

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

7 January 2021

Aspirin therapy in diabetes. American Diabetes Association

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

7 January 2021

Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

7 January 2021

The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802312

7 January 2021